Verrica Pharmaceuticals Inc.
VRCANasdaqCIK 1660334HealthcareFiscal year ends Dec 31
Reports and events: 158 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:37 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001660334-26-000025 |
| 2026-08-0616:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338273 |
| 2026-06-0916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-263722 |
| 2026-05-1216:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001660334-26-000014 |
| 2026-05-1216:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219395 |
| 2026-04-2016:10 ET | DEF 14A | Proxy statementPeriod 2026-06-05 | 0001193125-26-163961 |
| 2026-03-1108:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001660334-26-000008 |
| 2026-03-1108:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-101126 |
| 2025-12-3007:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-005417 |
| 2025-12-3006:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-335824 |
| 2025-11-2817:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001494695-25-000006 |
| 2025-11-2416:15 ET | SCHEDULE 13D | Ownership report, active investor | 0000902664-25-005145 |
| 2025-11-2408:19 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-292155 |
| 2025-11-1416:34 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001660334-25-000006 |
| 2025-11-1416:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-283078 |
| 2025-08-1216:20 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107358 |
| 2025-08-1216:11 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-178954 |
| 2025-07-3016:15 ET | 8-K | 3.01 Delisting notice | 0001193125-25-169309 |
| 2025-07-2308:00 ET | 8-K | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-162939 |
| 2025-07-0108:02 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-153471 |
| 2025-06-1216:27 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-25-139959 |
| 2025-06-0516:57 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-135949 |
| 2025-05-1316:36 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070452 |
| 2025-05-1316:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-118839 |
| 2025-04-2516:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-096909 |
| 2025-04-2207:15 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001193125-25-087838 |
| 2025-04-0216:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-071389 |
| 2025-03-1116:23 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-037172 |
| 2025-03-1116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-051957 |
| 2025-02-2116:15 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-25-032003 |
| 2025-01-3016:16 ET | 8-K | 3.01 Delisting notice | 0001193125-25-017264 |
| 2024-12-0916:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-273406 |
| 2024-11-2616:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-123093 |
| 2024-11-2116:55 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-263477 |
| 2024-11-2017:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-262615 |
| 2024-11-0518:25 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-120982 |
| 2024-11-0416:17 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-250638 |
| 2024-10-0816:16 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001193125-24-234391 |
| 2024-10-0116:37 ET | 8-K | 2.05 Exit or disposal costs | 0001193125-24-230240 |
| 2024-09-2716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-227975 |
| 2024-09-0616:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-215180 |
| 2024-08-2716:50 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-207814 |
| 2024-08-1408:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096669 |
| 2024-08-1407:56 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-200247 |
| 2024-08-0516:15 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-24-193923 |
| 2024-06-2816:17 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-24-172277 |
| 2024-06-1016:18 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-158353 |
| 2024-05-1507:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-138898 |
| 2024-05-1308:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058208 |
| 2024-05-1307:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-136715 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.